{
    "id": 29335,
    "fullName": "YAP1 over exp",
    "impact": "none",
    "proteinEffect": "no effect",
    "geneVariantDescriptions": [
        {
            "description": "YAP1 over exp indicates an over expression of the Yap1 protein and/or mRNA. However, the mechanism causing the over expression is unspecified.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 10413,
        "geneSymbol": "YAP1",
        "terms": [
            "YAP1",
            "COB1",
            "YAP",
            "YAP2",
            "YAP65",
            "YKI"
        ]
    },
    "variant": "over exp",
    "createDate": "02/12/2019",
    "updateDate": "02/12/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 15962,
            "approvalStatus": "Clinical Study - Cohort",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a retrospective analysis, patients with EGFR mutant lung adenocarcinoma harboring an acquired EGFR T790M mutation and expressing high levels of nuclear Yap1 protein prior to treatment with EGFR tyrosine kinase inhibitors (n=4) had significantly shorter overall survival (p<0.001) than patients in a corresponding group with low nuclear Yap1 expressing (n=9), but no difference in progression-free survival (p=0.221) (PMID: 29487002).",
            "molecularProfile": {
                "id": 31342,
                "profileName": "EGFR T790M EGFR act mut YAP1 over exp"
            },
            "therapy": {
                "id": 6870,
                "therapyName": "unspecified EGFR tyrosine kinase inhibitor",
                "synonyms": null
            },
            "indication": {
                "id": 3910,
                "name": "lung adenocarcinoma",
                "source": "DOID"
            },
            "responseType": "decreased response",
            "references": [
                {
                    "id": 14077,
                    "pubMedId": 29487002,
                    "title": "Overexpression of YAP1 in EGFR mutant lung adenocarcinoma prior to tyrosine kinase inhibitor therapy is associated with poor survival.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29487002"
                }
            ],
            "ampCapAscoEvidenceLevel": "NA",
            "ampCapAscoInferredTier": "NA"
        },
        {
            "id": 15961,
            "approvalStatus": "Clinical Study - Cohort",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a retrospective analysis, patients with EGFR mutant lung adenocarcinoma expressing high levels of nuclear Yap1 protein (n=15) prior to treatment with EGFR tyrosine kinase inhibitors had decreased progression-free survival (9.8 vs 14.2 months) and overall survival (21.1 vs 36.3 months) compared to patients with low nuclear Yap1 expression (PMID: 29487002).",
            "molecularProfile": {
                "id": 31343,
                "profileName": "EGFR act mut YAP1 over exp"
            },
            "therapy": {
                "id": 6870,
                "therapyName": "unspecified EGFR tyrosine kinase inhibitor",
                "synonyms": null
            },
            "indication": {
                "id": 3910,
                "name": "lung adenocarcinoma",
                "source": "DOID"
            },
            "responseType": "decreased response",
            "references": [
                {
                    "id": 14077,
                    "pubMedId": 29487002,
                    "title": "Overexpression of YAP1 in EGFR mutant lung adenocarcinoma prior to tyrosine kinase inhibitor therapy is associated with poor survival.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29487002"
                }
            ],
            "ampCapAscoEvidenceLevel": "NA",
            "ampCapAscoInferredTier": "NA"
        }
    ],
    "molecularProfiles": [
        {
            "id": 31341,
            "profileName": "YAP1 over exp",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 31342,
            "profileName": "EGFR T790M EGFR act mut YAP1 over exp",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 31343,
            "profileName": "EGFR act mut YAP1 over exp",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}